Author:
Burris Jessica L.,Borger Tia N.,Baker Timothy B.,Bernstein Steven L.,Ostroff Jamie S.,Rigotti Nancy A.,Joseph Anne M.
Abstract
AbstractThere are evidence-based treatments for tobacco dependence, but inequities exist in the access to and reach of these treatments. Traditional models of tobacco treatment delivery are “reactive” and typically provide treatment only to patients who are highly motivated to quit and seek out tobacco treatment. Newer models involve “proactive” outreach, with benefits that include increasing access to tobacco treatment, prompting quit attempts among patients with low motivation, addressing health disparities, and improving population-level quit rates. However, the definition of “proactive” is not clear, and adoption has been slow. This commentary introduces a comprehensive yet flexible model of proactive outreach and describes how proactive outreach can optimize clinical research and care delivery in these domains: (1) identifying the population, (2) offering treatment, and (3) delivering treatment. Dimensions relevant to each domain are the intensity of proactive outreach (low to high) and the extent to which proactive outreach activities rely on human interaction or are facilitated by information technology (IT). Adoption of the proposed proactive outreach model could improve the precision and rigor with which tobacco cessation research and tobacco treatment programs report data, which could have a positive effect on care delivery and patient outcomes.
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco product use among adults — United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(46):1736-1742. doi:https://doi.org/10.15585/mmwr.mm6946a4
2. Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting smoking among adults- United States, 2000-2015. MMWR Morb Mortal Wkly Rep. 2017;65(52):1457-1464. doi:https://doi.org/10.15585/mmwr.mm6552a1
3. Jha P, Ramasundarahettige C, Landsman V, et al. 21st- century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368:341-350.
4. Koh HK, Piotrowski JJ, Kumanyika S, Fielding JE. Healthy people: A 2020 vision for the social determinants approach. Heal Educ Behav. 2011;38(6):551-557. doi:https://doi.org/10.1177/1090198111428646
5. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:14651858.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献